从并发症防治探讨经尿道前列腺手术由电切到铥激光转换的发展趋势

夏术阶, 王小海, 张泽霖. 从并发症防治探讨经尿道前列腺手术由电切到铥激光转换的发展趋势[J]. 临床泌尿外科杂志, 2023, 38(5): 321-323. doi: 10.13201/j.issn.1001-1420.2023.05.001
引用本文: 夏术阶, 王小海, 张泽霖. 从并发症防治探讨经尿道前列腺手术由电切到铥激光转换的发展趋势[J]. 临床泌尿外科杂志, 2023, 38(5): 321-323. doi: 10.13201/j.issn.1001-1420.2023.05.001
XIA Shujie, WANG Xiaohai, ZHANG Zelin. The development trend of the conversion from TURP to thulium laser in transurethral prostate surgery from the prevention and treatment of complications[J]. J Clin Urol, 2023, 38(5): 321-323. doi: 10.13201/j.issn.1001-1420.2023.05.001
Citation: XIA Shujie, WANG Xiaohai, ZHANG Zelin. The development trend of the conversion from TURP to thulium laser in transurethral prostate surgery from the prevention and treatment of complications[J]. J Clin Urol, 2023, 38(5): 321-323. doi: 10.13201/j.issn.1001-1420.2023.05.001

从并发症防治探讨经尿道前列腺手术由电切到铥激光转换的发展趋势

详细信息
    作者简介:

    夏术阶,教授、博士生导师,上海交通大学泌尿外科研究所所长,上海市领军人才。中国医师协会男科与性医学分会会长、世界华人泌尿外科医师协会会长、中国医学装备协会泌尿外科分会会长、中国医师协会泌尿外科分会副会长。获得国家科技进步二等奖1项、省部级一等奖4项,获得上海医学发展杰出贡献奖,吴阶平泌尿外科奖,世界杰出华人医师霍英东奖,上海市五一劳动奖章。在国内外期刊发表学术论文810篇,其中SCI收录222篇。获得国家授权专利66项,其中发明专利33项。主编(译)权威专著共2 174万字。创新建立前列腺创面修复新理论与精准外科干预体系。解决了前列腺增生症诊疗相关的关键科学难题,写入了欧洲指南、中国指南、美国坎贝尔沃什泌尿外科学和史密斯泌尿外科经典教科书

    通讯作者: 夏术阶,E-mail:xsjurologist@163.com
  • 中图分类号: R697

The development trend of the conversion from TURP to thulium laser in transurethral prostate surgery from the prevention and treatment of complications

More Information
  • 良性前列腺增生(BPH)是引起中老年男性排尿障碍最常见的一种良性进展性疾病,其患者人群日益庞大,亟待手术干预的患者也逐渐增多。经尿道前列腺电切术(TURP)被认为是治疗BPH的金标准,但近年来逐渐被激光取代。本文将从并发症防治的角度综述经尿道前列腺手术由电切到铥激光的转换,以期为铥激光更安全广泛地应用于BPH治疗提供借鉴。
  • 加载中
  • [1]

    Lim KB. Epidemiology of clinical benign prostatic hyperplasia[J]. Asian J Urol, 2017, 4(3): 148-151. doi: 10.1016/j.ajur.2017.06.004

    [2]

    Wang B, Zhang S, Sun C, et al. Comparison between a transurethral prostate split and transurethral prostate resection for benign prostatic hyperplasia treatment in a small prostate volume: a prospective controlled study[J]. Ann Transl Med, 2020, 8(16): 1016. doi: 10.21037/atm-20-5462

    [3]

    Fagerström T, Nyman CR, Hahn RG. Bipolar transurethral resection of the prostate causes less bleeding than the monopolar technique: a single-centre randomized trial of 202 patients[J]. BJU Int, 2010, 105(11): 1560-1564. doi: 10.1111/j.1464-410X.2009.09052.x

    [4]

    Demirel I, Ozer AB, Bayar MK, et al. TURP syndrome and severe hyponatremia under general anaesthesia[J]. BMJ Case Rep, 2012: bcr-2012-006899.

    [5]

    Teo JS, Lee YM, Ho HSS. An update on transurethral surgery for benign prostatic obstruction[J]. Asian J Urol, 2017 4(3): 195-198. doi: 10.1016/j.ajur.2017.06.006

    [6]

    Barbagli G, Kulkarni SB, Joshi PM, et al. Repair of sphincter urethral strictures preserving urinary continence: surgical technique and outcomes[J]. World J Urol, 2019, 37(11): 2473-2479. doi: 10.1007/s00345-019-02686-x

    [7]

    Ahyai SA, Gilling P, Kaplan SA, et al. Meta-analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic enlargement[J]. Eur Urol, 2010, 58(3): 384-397. doi: 10.1016/j.eururo.2010.06.005

    [8]

    Yan P, Cui Y, Huang Y, et al. Intraoperative and postoperative outcomes of thulium laser enucleation versus bipolar resection in the transurethral treatment of benign prostatic hyperplasia: a meta-analysis[J]. Lasers Med Sci, 2022, 37(5): 2517-2525. doi: 10.1007/s10103-022-03519-x

    [9]

    Zhang HY. Prostate artery embolization on lower urinary tract symptoms related to benign prostatic hyperplasia: A systematic review and metaanalysis[J]. World J Clin Cases, 2022, 10(32): 11812-11826. doi: 10.12998/wjcc.v10.i32.11812

    [10]

    Huang X, Chen XX, Chen X, et al. Feasibility of anterior lobe-preserving transurethral enucleation and resection of prostate on improving urinary incontinence in patients with benign prostatic hyperplasia: A retrospective cohort study[J]. Medicine(Baltimore), 2023, 102(7): e32884.

    [11]

    Insausti I, Sáez de Ocáriz A, Galbete A, et al. Randomized Comparison of Prostatic Artery Embolization vs Transurethral Resection of the Prostate for Treatment of Benign Prostatic Hyperplasia[J]. J Vasc Interv Radiol, 2020, 31(6): 882-890. doi: 10.1016/j.jvir.2019.12.810

    [12]

    Chen LK, Lai YW, Chiu LP, et al. Significant relationship between parameters measured by transrectal color Doppler ultrasound and sexual dysfunction in patients with BPH 12 mo after TURP[J]. BMC Urol, 2021, 21(1): 9. doi: 10.1186/s12894-020-00776-2

    [13]

    Ottaiano N, Shelton T, Sanekommu G, et al. Surgical Complications in the Management of Benign Prostatic Hyperplasia Treatment[J]. Curr Urol Rep, 2022, 23(5): 83-92. doi: 10.1007/s11934-022-01091-z

    [14]

    Jiang Q, Xia S. Two-micron(Thulium)Laser Prostatectomy: An Effective Methodsfor BPH Treatment[J]. Curr Bladder Dysfunct Rep, 2014, 9(2): 142-144. doi: 10.1007/s11884-014-0233-z

    [15]

    Marien T, Kadihasanoglu M, Miller N. Complications of endoscopic procedures for benign prostatic hyperplasia[M]. Complications of Urologic Surgery 5th ed Philadelphia, PA: Elsevier. 2018.

    [16]

    Parker DC, Simhan J. Management of complications after surgical outlet reduction for benign prostatic obstruction[J]. Can J Urol, 2015, 22 Suppl 1: 88-92.

    [17]

    Zhang F, Shao Q, Herrmann TR, et al. Thulium laser versus holmium laser transurethral enucleation of the prostate: 18-month follow-up data of a single center[J]. Urology, 2012, 79(4): 869-874. doi: 10.1016/j.urology.2011.12.018

    [18]

    Świniarski PP, Stępień S, Dudzic W, et al. Thulium laser enucleation of the prostate(TmLEP)vs. transurethral resection of the prostate(TURP): evaluation of early results[J]. Eur Urol Suppl, 2012, 9(6): 551-551.

    [19]

    Carmignani L, Bozzini G, Macchi A, et al. Sexual outcome of patients undergoing thulium laser enucleation of the prostate for benign prostatic hyperplasia[J]. Asian J Androl, 2015, 17(5): 802-806. doi: 10.4103/1008-682X.139255

    [20]

    Palmero-Martí JL, Panach-Navarrete J, Valls-González L, et al. Comparative study between thulium laser(Tm: YAG)150W and greenlight laser(LBO: ND-YAG)120W for the treatment of benign prostatic hyperpplasia: Short-term efficacy and security[J]. Actas Urol Esp, 2017, 41(3): 188-193. doi: 10.1016/j.acuro.2016.09.009

    [21]

    Primiceri G, Castellan P, Marchioni M, et al. Bladder neck contracture after endoscopic surgery for benign prostatic obstruction: incidence, treatment, and outcomes[J]. Curr Urol Rep, 2017, 18(10): 79. doi: 10.1007/s11934-017-0723-6

    [22]

    Redshaw JD, Broghammer JA, Smith TG, et al. Intralesional Injection of Mitomycin C at Transurethral Incision of Bladder Neck Contracture May Offer Limited Benefit: TURNS Study Group[J]. J Urol, 2015, 193(2): 587-592. doi: 10.1016/j.juro.2014.08.104

    [23]

    Mavuduru RM, Mandal AK, Singh SK, et al. Comparison of HoLEP and TURP in Terms of Efficacy in the Early Postoperative Period and Perioperative Morbidity[J]. Urol Int, 2009, 82(2): 130-135. doi: 10.1159/000200786

    [24]

    Herrmann T, Wolters M. Transurethral anatomical enucleation of the prostate with Tm: YAG support(ThuLEP): Evolution and variations of the technique. The inventors' perspective[J]. Andrologia, 2020, 52(5): e13587.

    [25]

    Elkoushy, Mohamed, A, et al. Reoperation After Holmium Laser Enucleation of the Prostate for Management of Benign Prostatic Hyperplasia: Assessment of Risk Factors with Time to Event Analysis[J]. J Endourol, 2015, 29(7): 797-804. doi: 10.1089/end.2015.0060

  • 加载中
计量
  • 文章访问数:  1910
  • PDF下载数:  992
  • 施引文献:  0
出版历程
收稿日期:  2023-04-10
刊出日期:  2023-05-06

目录